© 2022 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Glaucoma
Less is more with redesigned probe for MicroPulse TLT for glaucoma
July 06, 2022
The lower energy applications and slower sweep speeds offer marked IOP reductions in patients.
Researchers find association between glaucoma and chronic kidney disease
June 30, 2022
A team of investigators from the Yong Loo Lin School of Medicine at the National University of Singapore has found that there is a bidirectional association between chronic kidney disease and glaucoma.
POAG study hopes to open a new avenue for therapies that are for helping treat patients that develop primary open angle glaucoma
June 05, 2022
Presented at ARVO 2022, research from Mass Eye and Ear hopes to open a new avenue for therapies that are for helping treat patients that develop primary open angle glaucoma.
Advancements in cyclophotocoagulation: The good, the better and the best
May 31, 2022
Each new generation of cyclophotocoagulation options results in more accurate visualisation of the ciliary processes, greater ease of use and fewer complications.
A new treatment paradigm with ab-interno canaloplasty for POAG
May 10, 2022
With minimally invasive surgery procedures becoming increasingly popular in glaucoma management, canaloplasty using an ab-interno surgical technique offers enhanced natural aqueous outflow in open-angle glaucoma.
Nanoemulsion formulation enhances IOP reduction, study finds
May 07, 2022
In research sponsored by Skye Bioscience Inc., investigators at the University of Mississippi have demonstrated stronger and longer-lasting reduction of intraocular pressure when a proprietary molecule, SBI-100, is formulated as a nanoemulsion containing the mucoadhesive agent Carbopol 940.
Chronic IOP elevation affects cerebrovascular reactivity in murine visual cortex, linked to widespread brain changes
May 02, 2022
Investigators from the New York University Grossman School of Medicine presented data at the ARVO 2022 annual meeting that concluded mapping of the relative cerebrovascular reactivity in the murine brain showed widespread brain changes resulting from the chronic IOP elevation and demonstrates vascular involvement in glaucoma both within and beyond the primary visual pathways.
Weekly review in ophthalmology: April 9-April 15
April 15, 2022
An end-of-week review of what happened in ophthalmology from April 9-April 15.
First MINIject surgery completed in the UK
April 10, 2022
iStar Medical announced the expansion of its commercial rollout of its MIGS implant MINIject® to the UK.
First patient treated in TRIDENT European trial
March 30, 2022
Novel trial design will compare safety and effectiveness outcomes for the OMNI Surgical System and the iStent inject in lowering IOP as a standalone treatment option without concomitant cataract surgery.